Floatz logo

SOMATOTROPIN (OX), 127-L-LEUCINE-

Penile Carcinoma

German Cancer Research Centerprotein_peptidePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Penile Carcinoma cohort.

Asset / SponsorPhaseRating
Bms-907351
National Cancer Institute (NCI)
Phase 2B
Nivolumab
National Cancer Institute (NCI)
Phase 2B
Cyclophosphamide
HRYZ Biotech Co.
Phase 2B
Ipilimumab
National Cancer Institute (NCI)
Phase 2B
Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457
M.D. Anderson Cancer Center
Phase 2CCC

View all 14 →

Same molecule, other indications

SOMATOTROPIN (OX), 127-L-LEUCINE- is also rated in:

breast carcinomaDormant
CC
Indicative ·
41 / 100
View asset →
sarcomaDormant
C
Indicative ·
39 / 100
View asset →
colorectal cancerDormant
C
Indicative ·
36 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →